2023 Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy. Ang Li, Sarah B. May, Jennifer La, Kylee L. Martens, Christopher I. Amos, Christopher R. Flowers, Nhan V. Do, Mary T. Brophy, Vipul Chitalia, Katya Ravid, John Michael Gaziano, Nathanael R. Fillmore American Journal of Hematology98(8), 1214-1222 U.S. Veterans and VA Data Retrospective Cohort Study Cancer-Associated Thrombosis Immune Checkpoint Inhibitors Risk Factors
2023 Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems. Ang Li†, Jennifer La†, Sarah B. May, Danielle Guffey, Costa Wilson L. da, Christopher I. Amos, Raka Bandyo, Emily M. Milner, Karen M. Kurian, Daniel C. R. Chen, Nhan V. Do, Carolina Granada, Nimrah Riaz, Mary T. Brophy, Vipul Chitalia, J. Michael Gaziano, David A. Garcia, Marc Carrier, Christopher R. Flowers, Neil A. Zakai‡, Nathanael R. Fillmore‡† Equal first authorship · ‡ Equal senior authorship Journal of Clinical Oncology41(16), 2926-2938 Cancer-Associated Thrombosis Predictive Modeling Retrospective Cohort Study External Validation U.S. Veterans and VA Data
2023 Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care System. Kylee L. Martens†, Ang Li†, Jennifer La, Sarah B. May, Kaitlin N. Swinnerton, Hannah Tosi, Danne C. Elbers, Nhan V. Do, Mary T. Brophy, J. Michael Gaziano, Saran Lotfollahzadeh, Vipul Chitalia, Katya Ravid, Nathanael R. Fillmore† Equal first authorship JAMA Network Open6(6), e2317945 U.S. Veterans and VA Data Retrospective Cohort Study Electronic Health Records Cancer-Associated Thrombosis Health Disparities
